Learn how finerenone improves heart failure outcomes in frail patients - discover the latest evidence and clinical guidance.

An ejection fraction >35% is unconventional to be considered "preserved," so the results of this trial are inconclusive on whether patients with heart failure and ejection fractions usually ...

Targeting a systolic blood pressure (SBP) below 130 mmHg may significantly reduce hospitalizations in patients with heart ...

The American College of Cardiology has issued new guidelines recommending weight management medications as first-line ...

The findings provide molecular and functional evidence that deficiency of XBP1-EDEM2 leads to lipid toxicity in the heart, accelerating the onset and development of heart failure in metabolic ...

Despite accounting for a considerable number of deaths among HFpEF patients, sudden cardiac death (SCD) remains poorly ...

GPs can start treatment with certain heart failure drugs that previously had to be initiated by a specialist, NICE has said.

Shifamed‘s Adona Medical announced today that it completed enrollment in the ATHENS-HF first-in-human study of its ...

Finerenone treatment vs placebo was associated with a reduced risk for new-onset diabetes by 24% among patients with HFmrEF or HFpEF.

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, ...

Jim Boeheim, the legendary Syracuse University men's basketball coach who led the team to over 1,100 wins, will be in Rochester on Wednesday.

Adona Medical, a Shifamed portfolio company that is developing one of the world's first combined therapeutic/diagnostic ...